Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone844-919-9990
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$3.30 million
Profitability
Miscellaneous
Employees62
OptionableNot Optionable
Nexeon Medsystems (OTCMKTS:NXNN) Frequently Asked Questions
What is Nexeon Medsystems' stock symbol?
Nexeon Medsystems trades on the OTCMKTS under the ticker symbol "NXNN."
How were Nexeon Medsystems' earnings last quarter?
Nexeon Medsystems Inc (OTCMKTS:NXNN) released its quarterly earnings data on Monday, November, 19th. The company reported ($0.71) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.37) by $0.34. The firm earned $1.98 million during the quarter, compared to analyst estimates of $2.66 million. Nexeon Medsystems had a negative net margin of 16.85% and a negative return on equity of 50.24%. View Nexeon Medsystems' Earnings History.
When is Nexeon Medsystems' next earnings date?
Has Nexeon Medsystems been receiving favorable news coverage?
Headlines about NXNN stock have been trending somewhat positive recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Nexeon Medsystems earned a daily sentiment score of 1.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Nexeon Medsystems' key competitors?
Some companies that are related to Nexeon Medsystems include Precision Optics (PEYE), Digirad (DRAD), ENDRA Life Sciences (NDRA), Non-Invasive Monitoring Systems (NIMU), Aradigm (ARDM), Vaso (VASO), CHF Solutions (CHFS), Reshape Lifesciences (RSLS), Escalon Medical (ESMC), Fc Global Realty (FCRE), Trimedyne (TMED), Magna-Lab (MAGAA), Guided Therapeutics (GTHP), SpectraScience (SCIE) and Newcardio (NWCI).
Who are Nexeon Medsystems' key executives?
Nexeon Medsystems' management team includes the folowing people:
- Mr. William Rosellini M.B.A., J.D., MBA, Chairman & CEO (Age 39)
- Mr. Christopher R. Miller, Chief Financial Officer (Age 49)
- Dr. Emily Hamilton Rosellini, Director of Emerging Therapy for NXPROC (Age 38)
How do I buy shares of Nexeon Medsystems?
Shares of NXNN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nexeon Medsystems' stock price today?
One share of NXNN stock can currently be purchased for approximately $2.10.
How big of a company is Nexeon Medsystems?
Nexeon Medsystems has a market capitalization of $4.25 million and generates $3.30 million in revenue each year. The company earns $-2,170,000.00 in net income (profit) each year or ($3.64) on an earnings per share basis. Nexeon Medsystems employs 62 workers across the globe.
What is Nexeon Medsystems' official website?
How can I contact Nexeon Medsystems?
Nexeon Medsystems' mailing address is 1910 PACIFIC AVENUE SUITE 20000, DALLAS TX, 75201. The company can be reached via phone at 844-919-9990 or via email at [email protected]
MarketBeat Community Rating for Nexeon Medsystems (OTCMKTS NXNN)
MarketBeat's community ratings are surveys of what our community members think about Nexeon Medsystems and other stocks. Vote "Outperform" if you believe NXNN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NXNN will underperform the S&P 500 over the long term. You may vote once every thirty days.
